Antibody Repertoires - Past, Present and Future

IBC's Antibody Engineering & Therapeutics event taking place December 7-10 in San Diego is the #1 forum for academia and industry to connect for scientific exchange and networking in Antibody Engineerings & Therapeutics, Immunobiology and Next-Generation Binders. To give you a sneak peek at the high caliber of the content presented at the conference - we would like to give you FREE access to complete videos from some of the 2014 presentations.

We hope to see you in San Diego this December!

Share this article with your social network, just click below to share now!

Share |

What did last year's Antibody Engineering & Therapeutics attendees have to say about their experience?

See what attendees of last year's Antibody Engineering & Therapeutics had to say...

"Comprehensive coverage. In-depth analyses of the past, present and outlook of the antibody therapyfield/industry" - Li-Hsien Wang, Regeneron


"I am new in the antibody therapeutic field and this conference provides significant amounts of valuable information to me." - Ulrik Lademann, Senior Scientist, Symphogen

"This is best meeting dedicated to Antibodies! Small enough to be able to be able to interact with people and big enough to cover all the important topics" - Monica Schaller, University Hospital Bern Inselspit

"Great conference, inspiring atmosphere, very motivating speakers and encouraging networking sessions!! Would love to come back!" - Priyal Thakur, BD Biosciences

"Great conference! Informative and addresses state-of-the-art advances in antibody/drug technologies." - James Tamura, Macrogenics

"Beautiful overview on antibody modeling strategies of different players on the market!" - Tobias Raum, Amgen Research Munich

"The most updated conference on Antibody Engineering & Therapeutics" - Jean-Luc Teillaud, INSERM, France

"The workshop program continues to be a venue for in-depth exploration of specialty topics on antibodies" - Ray Sweet, Senior Director and Fellow, Biologics Research, Janssen R&D

"Informative and Timely!" - Colin Brenan, CTO, R&D, HiFiBio BV

"World class group of leading antibody researchers" - Caroll Osgood, Alleghany Brain and Spine


Don't miss out on the #1 forum for academia and industry to connect for scientific exchange and networking in antibody engineering & therapeutics, immunobiology and next-generation binders.

Check out the complete program here.

Register today with the code D15172BLOG and save $550!

Share this article with your social network, just click below to share now!

Share |

Highlights from the 2014 Antibody Engineering & Therapeutics Conference

The annual Antibody Engineering & Therapeutics is the #1 forum for academia and industry to connect for scientific exchange and networking in antibody engineering & therapeutics, immunobiology and next-generation binders.  The 2015 event is taking place December 7-10 in San Diego, CA. Below are highlights from the 2014 event...




Interested in attending the 2015 event? Register today and save $550 when you use the code D15172BLOG

Share this article with your social network, just click below to share now!

Share |

Full Program Now Available for Antibody Engineering & Therapeutics 2014 Meeting

The final agenda is now available for IBC's 25th Annual Antibody Engineering & Therapeutics meeting, taking place on December 7-11, 2014 in Huntington Beach, CA.

Accelerate your antibody research, discovery efforts and clinical programs by joining 750 of your colleagues at the #1 forum for academia and industry to connect for scientific exchange and networking in antibody engineering & therapeutics, immunobiology and next-generation binders.

Download the 2014 agenda today.

Watch a 3-minute YouTube highlight video of last year’s meeting:


Why Do Attendees Return Year After Year?

• - Find new antibody targets beyond the low-hanging fruit - strategies for targeting difficult antigens
• - Learn about development strategies for ADCs, bispecifics, fusions, antibody combinations and other complex molecules/next-generation antibodies
• - Exploit immune checkpoints for target discovery, new agent design and preclinical/clinical development
• - Engineer improved antibody developability - expression, solubility and polyreactivity
• - Develop antibody therapeutics for multiple non-cancer indications including diabesity, autoimmune disease and multiple sclerosis
• - Get the latest data and lessons learned from numerous preclinical and clinical antibody therapeutic projects

As a reader of this blog, when you register to join us in Huntington Beach and mention code XD14172BLOG, you'll save 20% off the standard rate.  Have any questions or want to get involved?  Reach out to Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |